HomeCompareKDVD vs MRK

KDVD vs MRK: Dividend Comparison 2026

KDVD yields 0.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.0K in total portfolio value
10 years
KDVD
KDVD
● Live price
0.76%
Share price
$25.62
Annual div
$0.20
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$80.20
Full KDVD calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KDVD vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKDVDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KDVD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KDVD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KDVD
Annual income on $10K today (after 15% tax)
$64.87/yr
After 10yr DRIP, annual income (after tax)
$68.17/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,260.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KDVD + MRK for your $10,000?

KDVD: 50%MRK: 50%
100% MRK50/50100% KDVD
Portfolio after 10yr
$38.8K
Annual income
$4,939.17/yr
Blended yield
12.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KDVD
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KDVD buys
0
MRK buys
0
No recent congressional trades found for KDVD or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKDVDMRK
Forward yield0.76%2.76%
Annual dividend / share$0.20$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20.8K$56.8K
Annual income after 10y$80.20$9,798.13
Total dividends collected$784.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KDVD vs MRK ($10,000, DRIP)

YearKDVD PortfolioKDVD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,776$76.32$11,206$366.19$430.00MRK
2$11,608$76.86$12,650$502.35$1.0KMRK
3$12,497$77.38$14,407$694.19$1.9KMRK
4$13,450$77.86$16,585$967.82$3.1KMRK
5$14,470$78.31$19,342$1,363.89$4.9KMRK
6$15,562$78.74$22,913$1,947.19$7.4KMRK
7$16,730$79.14$27,662$2,823.89$10.9KMRK
8$17,981$79.51$34,159$4,173.35$16.2KMRK
9$19,319$79.87$43,337$6,308.80$24.0KMRK
10$20,752$80.20$56,776$9,798.13$36.0KMRK

KDVD vs MRK: Complete Analysis 2026

KDVDStock

KDVD seeks total returns by investing primarily in US small- and mid-cap companies that pay dividends or are expected to begin doing so. Investments span the entire dividend spectrum, including established high-yield businesses, steady dividend growers, and companies likely to initiate dividends, or initiate payouts or return cash through buybacks. The fund uses fundamental research supported by a deep team of sector analysts to identify stocks trading below their intrinsic value. It also evaluates factors such as earnings expectations, dividend sustainability, balance-sheet strength, management quality, and potential catalysts that could unlock additional value. The fund generally holds securities for more than a year but may sell positions when fundamentals deteriorate, the position becomes overweight, or more compelling opportunities emerge.

Full KDVD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KDVD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KDVD vs SCHDKDVD vs JEPIKDVD vs OKDVD vs KOKDVD vs MAINKDVD vs JNJKDVD vs ABBVKDVD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.